Nachrichten zur Pfizer Aktie

JPMORGAN stuft PFIZER INC auf Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen zum vierten Quartal auf "Neutral"…

UBS stuft PFIZER INC auf Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer nach Zahlen auf "Neutral" mit einem Kursziel…

BioNTech Aktie: Pfizer überrascht positiv, doch Anleger bleiben zurückhaltend

Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid…

Pfizer beats Q4, FY 24 earnings estimates, stock flat in early trading

…

Compared to Estimates, Pfizer (PFE) Q4 Earnings: A Look at Key Metrics

The headline numbers for Pfizer (PFE) give insight into how the company performed in the quarter ended December 2024, but…

PFEs Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS

Pfizers late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS with…

UBS belässt Pfizer auf Neutral - Ziel 29 Dollar

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer nach Zahlen auf "Neutral" mit einem Kursziel…

Stocks making the biggest moves premarket: Pfizer, PepsiCo, Palantir, Merck & more

These are the stocks posting the largest moves in premarket trading.…

Pfizer Aktie: Auf kurze Sicht ist alles gut

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…

BioNTech-Partner Pfizer: Besser als erwartet, aber…

Der US-Pharmakonzern und Partner von BioNTech, Pfizer, hat am heutigen Dienstag seine Zahlen für das vierte Quartal sowie das Gesamtjahr…

BioNTech-Partner Pfizer: Besser als erwartet, aber…

Der US-Pharmakonzern und Partner von BioNTech, Pfizer, hat am heutigen Dienstag seine Zahlen für das vierte Quartal sowie das Gesamtjahr…

Pfizer übertrifft Umsatzerwartung - Aktie gefragt

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen Ausblick für das neue…

Pfizer übertrifft Umsatzerwartung - Aktie gefragt

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen…

Pfizer beats fourth-quarter profit estimates on cost-cutting efforts

U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and better-than-expected sales of…

Pfizer shows profit growth from cost cuts and steadier COVID sales

…

Pfizer’s fourth quarter sales and earnings top expectations

Pfizer Inc (NYSE:PFE, ETR:PFE) posted stronger-than-expected financial results for the fourth quarter and reaffirmed its 2025 revenue guidance. The company...…

Pfizer tops Q4 sales and earnings expectations

Pfizer Inc (NYSE:PFE, ETR:PFE) posted stronger-than-expected financial results for the fourth quarter and reaffirmed its 2025 revenue guidance. The company...…

The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb

Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb are included in this Analyst Blog.…

Pre-Markets Flat Ahead of JOLTS; Q4 Earnings for PFE, PYPL, PEP & More

Pfizer (PFE) put up its most impressive quarterly numbers in recent memory today.…

Ausblick: Pfizer stellt Zahlen zum jüngsten Quartal vor

Pfizer wird am 04.02.2025 in der Finanzkonferenz die Quartalszahlen zum jüngsten Jahresviertel - Abschlussdatum 31.12.2024 - vorstellen.16 Analysten gehen in…

Will Non-COVID Drugs Drive PFEs Top Line in Q4 Earnings?

Pfizers non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…

Smaller US winter COVID wave adds pressure to Pfizer turnaround

…

Smaller US winter COVID wave adds pressure to Pfizer turnaround

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years,…

Better Artificial Intelligence Stock: SoundHound AI vs. Palantir Technologies

There are thousands of publicly traded stocks, and dozens that could be considered artificial intelligence (AI) stocks. So, lets sift through…

Want High Dividends and Low Risk? This ETF Can Be an Ideal Option for Your Portfolio.

Dividend stocks can provide you with a lot of recurring income over the long term. But they can also prove…

Pfizer resolves conservative challenge to diversity fellowship program

Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to…

Pfizer resolves conservative challenge to diversity fellowship program By Reuters

Pfizer resolves conservative challenge to diversity fellowship program…

Pfizer director Daniel Cronin sells shares worth $20,140 By Investing.com

Pfizer director Daniel Cronin sells shares worth $20,140…

NYC Project to Convert Former Pfizer Headquarters Lands $135 Million Loan

The effort to convert Pfizer Inc.’s former New York headquarters into residences secured financing to help developers forge ahead on…

Pfizer Aktie: Negatives Sentiment für den Pharmasektor in 2025

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse der Citigroup: 1. Kurszielsenkung und Begründung Analyst Geoff Meacham hat das Kursziel für die Aktie von Pfizer…

Market Panic Over DeepSeek? Why Nvidias $500 Billion Drop Is Pure Hysteria.

Yesterday, a piece of breaking news sent technology stocks into a tailspin. The Chinese start-up DeepSeek developed an AI chatbot…

I Own 4 High-Yield Dividend Stocks. Heres Why I Own Each One.

When paired with dividend reinvestment, high-yield dividend stocks have demonstrated remarkable outperformance compared to the S&P 500 over holding periods…

This Chinese MIT Physicist Uses AI To Find New Drugs. Next Up: Solar Panels And EV Batteries

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to…

PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor

A Bloomberg article suggests activist investor Starboard cut Pfizer some slack by not nominating any director on the companys board…

Have $500? 2 High-Yield Dividend Stocks to Buy Right Now

Dividend stocks can be a great way to boost your portfolios growth potential or provide a form of passive income…

Pfizer succeeds in late-stage trial for colorectal cancer therapy

…

Got $100? This Top Dividend ETF Is a No-Brainer Buy Right Now.

Dividend stocks make great long-term investments. For example, an investor who bought $100 worth of average dividend stocks in 1973…

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

Some stocks pay juicy dividends for a while only for the income to later dwindle. Others generate consistent and reliable…

Pfizer to pay $59.7 million over kickbacks for migraine drug

…

Pfizer Aktie: Wie sind die Aussichten?

Der Pharmakonzern Pfizer verzeichnete am Freitag einen deutlichen Kursrückgang an der New Yorker Börse. Die Aktie des Unternehmens rutschte um…

Pfizer to pay $59.7 million over kickbacks for migraine drug By Reuters

Pfizer to pay $59.7 million over kickbacks for migraine drug…

Pfizer settles Biohaven kickback case with DOJ for $60M

…

Can This Beaten-Down Stock Bounce Back in 2025?

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales. But…

My Top 5 Stocks to Buy in Early 2025

Its the start of a new year, and that makes now the perfect time to load up on stocks that…

3 Dirt-Cheap Stocks to Buy in a Market Thats Priced for Perfection

How expensive is the stock market right now? The S&P 500 Shiller CAPE ratio is near its second-highest level ever.…

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever

Youve probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the…

3 Subtle Investing Mistakes I Wont Repeat in 2025 And Beyond

Its normal to make more than a few flubs while investing, especially when youre new. At the same time, we…

Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,000 in Passive Income in 2025

What would it take to make over $3,000 this year with only barely lifting a finger? My answer is having…

The Smartest Dividend Stocks to Buy With $100 Right Now

A little money can go a long way. Thats especially the case when you invest in stocks that pay you…